Forian Inc (FORA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Forian Inc (FORA) has a cash flow conversion efficiency ratio of 0.108x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($3.22 Million) by net assets ($29.78 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Forian Inc net asset quality index to measure how much of total assets are equity-financed.
Forian Inc - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Forian Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Forian Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Forian Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Forian Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
AV Tech Corp
TW:8072
|
-0.020x |
|
Tailyn Technologies
TWO:5353
|
0.057x |
|
Xtant Medical Holdings Inc
NYSE MKT:XTNT
|
0.106x |
|
C I Systems
TA:CISY
|
0.039x |
|
Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS
IS:LKMNH
|
-0.037x |
|
ETHZilla Corporation
NASDAQ:ETHZ
|
-0.106x |
|
Amoeba SA
PA:ALMIB
|
0.644x |
|
Great Elm Group Inc
NASDAQ:GEG
|
0.146x |
Annual Cash Flow Conversion Efficiency for Forian Inc (2019–2025)
The table below shows the annual cash flow conversion efficiency of Forian Inc from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see Forian Inc market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $29.78 Million | $2.89 Million | 0.097x | +929.98% |
| 2024-12-31 | $30.05 Million | $282.83K | 0.009x | -64.20% |
| 2023-12-31 | $27.72 Million | $728.82K | 0.026x | +103.81% |
| 2022-12-31 | $12.42 Million | $-8.58 Million | -0.691x | -0.80% |
| 2021-12-31 | $25.17 Million | $-17.25 Million | -0.685x | -81.64% |
| 2020-12-31 | $11.27 Million | $-4.25 Million | -0.377x | -110.27% |
| 2019-12-31 | $-281.03K | $-1.03 Million | 3.674x | -- |
About Forian Inc
Forian Inc. provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure operational, clinical and financial performance. It develops commercial, real-world evidence (RWE), and market access solutions and proprietary data-driven insights. The company's subscription and services-based solutions serve the life sciences, pharmaceutical … Read more